CHIARAMONTE, ELOISA
CHIARAMONTE, ELOISA
Universita' degli Studi di MILANO
Primary TSC2-/meth Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model
2022 C. Bernardelli, E. Chiaramonte, S. Ancona, S.M. Sirchia, A. Cerri, E.A. Lesma
Differential modulation of matrix metalloproteinases-2 and-7 in LAM/TSC cells
2021 S. Ancona, E. Orpianesi, C. Bernardelli, E. Chiaramonte, R. Chiaramonte, S. Terraneo, F. Di Marco, E. Lesma
Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis
2015 E. Lesma, E. Chiaramonte, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
LAM/TSC cell migration to uterus in an experimental model of lymphangioleiomyomatosis. Regulation by anti-epidermal growth factor receptor antibody and rapamycin
2014 E. Lesma, E. Chiaramonte, S. Ancona, A.M. Di Giulio, A. Gorio
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
2014 E. Lesma, S. Ancona, S.M. Sirchia, E. Orpianesi, V. Grande, P. Colapietro, E. Chiaramonte, A.M. Di Giulio, A. Gorio
ALTERAZIONI ISTOPATOLOGICHE INDOTTE DA CELLULE UMANE LAM/TSC IN TOPI NUDI: UN MODELLO DI LINFANGIOLEIOMIOMATOSI. REVERSIONE DEL DANNO CON ANTICORPO ANTI-EGFR
2012 E. Chiaramonte
Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice
2012 E. Lesma, E. Chiaramonte, E. Isaia, V. Grande, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
Characterization of LAM/TSC cells isolated from patient chylous
2010 E. Lesma, S. Ancona, V. Grande, S.M. Sirchia, E. Chiaramonte, S. Bosari, A.M. Di Giulio, A. Gorio
Development of a LAM model by using human TSC2 deficient smooth muscle cells derived from a renal angiomylipoma
2010 E. Lesma, E. Chiaramonte, V. Grande, S. Ancona, A.M. Di Giulio, A. Gorio
Un modello di linfangioleiomiomatosi con la somministrazione di cellule muscolari lisce umane TSC2-/-
2010 E. Lesma, E. Chiaramonte, V. Grande, S. Ancona, F. La Briola, M.P. Canevini, M. Corona, F. Ghelma, A.M. Di Giulio, A. Gorio
A mouse LAM model by endonasal administration of human TSC2 deficient smooth muscle cells
2010 E. Lesma, E. Chiaramonte, S. Ancona, V. Grande, A.M. Di Giulio, A. Gorio
Role of HMG-CoA reductase inhibitors in controlling TSC2-/- ASM cell growth and proliferation
2009 V. Grande, E. Lesma, S. Ancona, E. Chiaramonte, A.M. Di Giulio, A. Gorio
Pathogenesis and pharmacological evaluation of human TSC2 smooth muscle cells. Possible treatment options for TSC and lymphangioleiomyomatosis
2009 E. Lesma, V. Grande, S. Ancona, E. Chiaramonte, S.M. Sirchia, A.M. Di Giulio, A. Gorio
An epigenetic event may underlies the TSC features in TSC2 ASM cells
2009 E. Lesma, S. Ancona, S.M. Sirchia, V. Grande, E. Chiaramonte, S. Bosari, A.M. Di Giulio, A. Gorio
Human smooth muscle TSC2-/- cells cause lymphangiogenesis-like lung destruction in nude mice. Pharmacological repair
2009 E. Lesma, E. Chiaramonte, S. Ancona, V. Grande, R. Adami, A.M. Di Giulio, A. Gorio
Promoter methylation of TSC2 gene is important for pathogenesis of TSC and LAM lesions
2009 S. Ancona, E. Lesma, S.M. Sirchia, V. Grande, E. Chiaramonte, A.M. Di Giulio, A. Gorio